A Molecular Mechanism for Sequential Activation of a G Protein-Coupled Receptor
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
A Molecular Mechanism for Sequential Activation of a G Protein-Coupled Receptor. / Grundmann, Manuel; Tikhonova, Irina G; Hudson, Brian D; Smith, Nicola J; Mohr, Klaus; Ulven, Trond; Milligan, Graeme; Kenakin, Terry; Kostenis, Evi.
In: Cell Chemical Biology, Vol. 23, No. 3, 17.03.2016, p. 392-403.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - A Molecular Mechanism for Sequential Activation of a G Protein-Coupled Receptor
AU - Grundmann, Manuel
AU - Tikhonova, Irina G
AU - Hudson, Brian D
AU - Smith, Nicola J
AU - Mohr, Klaus
AU - Ulven, Trond
AU - Milligan, Graeme
AU - Kenakin, Terry
AU - Kostenis, Evi
N1 - Copyright © 2016 Elsevier Ltd. All rights reserved.
PY - 2016/3/17
Y1 - 2016/3/17
N2 - Ligands targeting G protein-coupled receptors (GPCRs) are currently classified as either orthosteric, allosteric, or dualsteric/bitopic. Here, we introduce a new pharmacological concept for GPCR functional modulation: sequential receptor activation. A hallmark feature of this is a stepwise ligand binding mode with transient activation of a first receptor site followed by sustained activation of a second topographically distinct site. We identify 4-CMTB (2-(4-chlorophenyl)-3-methyl-N-(thiazol-2-yl)butanamide), previously classified as a pure allosteric agonist of the free fatty acid receptor 2, as the first sequential activator and corroborate its two-step activation in living cells by tracking integrated responses with innovative label-free biosensors that visualize multiple signaling inputs in real time. We validate this unique pharmacology with traditional cellular readouts, including mutational and pharmacological perturbations along with computational methods, and propose a kinetic model applicable to the analysis of sequential receptor activation. We envision this form of dynamic agonism as a common principle of nature to spatiotemporally encode cellular information.
AB - Ligands targeting G protein-coupled receptors (GPCRs) are currently classified as either orthosteric, allosteric, or dualsteric/bitopic. Here, we introduce a new pharmacological concept for GPCR functional modulation: sequential receptor activation. A hallmark feature of this is a stepwise ligand binding mode with transient activation of a first receptor site followed by sustained activation of a second topographically distinct site. We identify 4-CMTB (2-(4-chlorophenyl)-3-methyl-N-(thiazol-2-yl)butanamide), previously classified as a pure allosteric agonist of the free fatty acid receptor 2, as the first sequential activator and corroborate its two-step activation in living cells by tracking integrated responses with innovative label-free biosensors that visualize multiple signaling inputs in real time. We validate this unique pharmacology with traditional cellular readouts, including mutational and pharmacological perturbations along with computational methods, and propose a kinetic model applicable to the analysis of sequential receptor activation. We envision this form of dynamic agonism as a common principle of nature to spatiotemporally encode cellular information.
U2 - 10.1016/j.chembiol.2016.02.014
DO - 10.1016/j.chembiol.2016.02.014
M3 - Journal article
VL - 23
SP - 392
EP - 403
JO - Chemistry and Biology
JF - Chemistry and Biology
SN - 2451-9448
IS - 3
ER -
ID: 189161795